Your browser doesn't support javascript.
loading
Yeast Two-Hybrid Analysis for Ubiquitin Variant Inhibitors of Human Deubiquitinases.
Pascoe, Natasha; Seetharaman, Ashwin; Teyra, Joan; Manczyk, Noah; Satori, Maria Augusta; Tjandra, Donna; Makhnevych, Taras; Schwerdtfeger, Carsten; Brasher, Bradley B; Moffat, Jason; Costanzo, Michael; Boone, Charles; Sicheri, Frank; Sidhu, Sachdev S.
Affiliation
  • Pascoe N; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3E1, Canada; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada.
  • Seetharaman A; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada.
  • Teyra J; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada.
  • Manczyk N; Department of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON M5G 1X5, Canada.
  • Satori MA; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada.
  • Tjandra D; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3E1, Canada; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada.
  • Makhnevych T; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada.
  • Schwerdtfeger C; Boston Biochem, a Bio-Techne Brand 840 Memorial Drive, Cambridge, MA 02139, USA.
  • Brasher BB; Boston Biochem, a Bio-Techne Brand 840 Memorial Drive, Cambridge, MA 02139, USA.
  • Moffat J; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3E1, Canada; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada; Canadian Institute for Advanced Research, Toronto, ON, M5
  • Costanzo M; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada; Canadian Institute for Advanced Research, Toronto, ON, M5G1Z8, Canada.
  • Boone C; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3E1, Canada; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada; Canadian Institute for Advanced Research, Toronto, ON, M5
  • Sicheri F; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3E1, Canada; Department of Biochemistry, University of Toronto, Toronto, ON M5S 1A8, Canada; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto, ON M5G 1X5, Canada.
  • Sidhu SS; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 3E1, Canada; Donnelly Centre for Cellular and Biomolecular Research, Banting and Best Department of Medical Research, University of Toronto, Toronto, ON, M5S3E1, Canada; Department of Biochemistry, University of Toronto, Toront
J Mol Biol ; 431(6): 1160-1171, 2019 03 15.
Article in En | MEDLINE | ID: mdl-30763569
ABSTRACT
We applied a yeast-two-hybrid (Y2H) analysis to screen for ubiquitin variant (UbV) inhibitors of a human deubiquitinase (DUB), ubiquitin-specific protease 2 (USP2). The Y2H screen used USP2 as the bait and a prey library consisting of UbVs randomized at four specific positions, which were known to interact with USP2 from phage display analysis. The screen yielded numerous UbVs that bound to USP2 both as a Y2H interaction in vivo and as purified proteins in vitro. The Y2H-derived UbVs inhibited the catalytic activity of USP2 in vitro with nanomolar-range potencies, and they bound and inhibited USP2 in human cells. Mutational and structural analysis showed that potent and selective inhibition could be achieved by just two substitutions in a UbV, which exhibited improved hydrophobic and hydrophilic contacts compared to the wild-type ubiquitin interaction with USP2. Our results establish Y2H as an effective platform for the development of UbV inhibitors of DUBs in vivo, providing an alternative strategy for the analysis of DUBs that are recalcitrant to phage display and other in vitro methods.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Ubiquitin / Ubiquitin Thiolesterase / Deubiquitinating Enzymes Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Year: 2019 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ubiquitin / Ubiquitin Thiolesterase / Deubiquitinating Enzymes Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Year: 2019 Type: Article